Model systems for studying cellular mechanisms of SCN1A-related epilepsy
SS Schutte, RJ Schutte, EV Barragan… - Journal of …, 2016 - journals.physiology.org
Mutations in SCN1A, the gene encoding voltage-gated sodium channel NaV1. 1, cause a
spectrum of epilepsy disorders that range from genetic epilepsy with febrile seizures plus to …
spectrum of epilepsy disorders that range from genetic epilepsy with febrile seizures plus to …
Stem cell-derived systems in toxicology assessment
Industrial sectors perform toxicological assessments of their potential products to ensure
human safety and to fulfill regulatory requirements. These assessments often involve animal …
human safety and to fulfill regulatory requirements. These assessments often involve animal …
Human cytomegalovirus compromises development of cerebral organoids
Congenital human cytomegalovirus (HCMV) infection causes a broad spectrum of central
and peripheral nervous system disorders, ranging from microcephaly to hearing loss. These …
and peripheral nervous system disorders, ranging from microcephaly to hearing loss. These …
[HTML][HTML] Comparisons of dual isogenic human iPSC pairs identify functional alterations directly caused by an epilepsy associated SCN1A mutation
Over 1250 mutations in SCN1A, the Nav1. 1 voltage-gated sodium channel gene, are
associated with seizure disorders including GEFS+. To evaluate how a specific mutation …
associated with seizure disorders including GEFS+. To evaluate how a specific mutation …
[HTML][HTML] Neural differentiation from pluripotent stem cells: the role of natural and synthetic extracellular matrix
Neural cells differentiated from pluripotent stem cells (PSCs), including both embryonic stem
cells and induced pluripotent stem cells, provide a powerful tool for drug screening, disease …
cells and induced pluripotent stem cells, provide a powerful tool for drug screening, disease …
Identification of fragile X syndrome specific molecular markers in human fibroblasts: a useful model to test the efficacy of therapeutic drugs
Fragile X syndrome (FXS) is the most frequent cause of inherited intellectual disability and
autism. It is caused by the absence of the fragile X mental retardation 1 (FMR1) gene …
autism. It is caused by the absence of the fragile X mental retardation 1 (FMR1) gene …
Functional differentiation of midbrain neurons from human cord blood-derived induced pluripotent stem cells
N Stanslowsky, A Haase, U Martin, M Naujock… - Stem cell research & …, 2014 - Springer
Introduction Human induced pluripotent stem cells (hiPSCs) offer great promise for
regenerative therapies or in vitro modelling of neurodegenerative disorders like Parkinson's …
regenerative therapies or in vitro modelling of neurodegenerative disorders like Parkinson's …
Transition from animal-based to human induced pluripotent stem cells (iPSCs)-based models of neurodevelopmental disorders: Opportunities and challenges
S Guerreiro, P Maciel - Cells, 2023 - mdpi.com
Neurodevelopmental disorders (NDDs) arise from the disruption of highly coordinated
mechanisms underlying brain development, which results in impaired sensory, motor and/or …
mechanisms underlying brain development, which results in impaired sensory, motor and/or …
Repression of SIRT1 promotes the differentiation of mouse induced pluripotent stem cells into neural stem cells
B Hu, Y Guo, C Chen, Q Li, X Niu, S Guo… - Cellular and molecular …, 2014 - Springer
The use of transplanting functional neural stem cells (NSCs) derived from induced
pluripotent stem cells (iPSCs) has increased for the treatment of brain diseases. As such, it is …
pluripotent stem cells (iPSCs) has increased for the treatment of brain diseases. As such, it is …
Human iPSC-derived neural stem cells engraft and improve pathophysiology of MPS I mice
CC Calhoun, SH Kan, AE Stover, JF Harb… - … Therapy Methods & …, 2024 - cell.com
Mucopolysaccharidosis type I (MPS I) is a metabolic disorder characterized by a deficiency
in α-l-iduronidase (IDUA), leading to impaired glycosaminoglycan degradation. Current …
in α-l-iduronidase (IDUA), leading to impaired glycosaminoglycan degradation. Current …